Rebecca R. Hozak

A phase 2, single‐arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

T. Choueiri, G. Hudes, W. Stadler, 2014, Cancer.